Recent

% | $
Quotes you view appear here for quick access.

NuPathe Inc. Message Board

  • arhdan9 arhdan9 Nov 16, 2013 9:21 AM Flag

    It's Maybe the Potential Partner(s) or Buyer of Nupathe Who Have Committed These Short Sales All Along

    For one and only one reason: it (they) don't want to pay $20 or $10 a share. Since path is a easily manipulated small biotech company, these manipulators may not be required to report to SEC for the shares involved in manipulation are less than 5% of the total shares.

    Just a possibility for anyone who has the means to do some investigation. But I hope it is just a one or two time events, and the price will be appreciated steadily starting from Monday!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PATH
4.25+0.07(+1.67%)Feb 21 4:00 PMEST